Recent evidence indicates that Insig1 expression is downregulated in kidney diseases such diabetic kidney disease (DKD) and renal mass loss (Kim et al, 2009; Liu et al, 2022), but no study has been done to determine the effect of Insig1 deficiency in the pathophysiology of CKD or PTCs fibrosis. This evidence concerns the gene INSIG1 and kidney disorder.